The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gorczynski, R. M.
Right arrow Articles by Clark, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gorczynski, R. M.
Right arrow Articles by Clark, D.
The Journal of Immunology, 2000, 165: 4854-4860.
Copyright © 2000 by The American Association of Immunologists

Receptor Engagement on Cells Expressing a Ligand for the Tolerance-Inducing Molecule OX2 Induces an Immunoregulatory Population That Inhibits Alloreactivity In Vitro and In Vivo1

Reginald M. Gorczynski2,*,{dagger}, Kai Yu* and David Clark*,{ddagger}

* University Health Network, Toronto, Canada; {dagger} Departments of Surgery and Immunology, University of Toronto, Toronto, Canada; and {ddagger} Departments of Medicine, Pathology, and Molecular Medicine, Obstetrics and Gynecology, McMaster University, Hamilton, Ontario, Canada

Increased survival of C57BL/6 renal allografts following portal vein donor-specific pretransplant immunization of C3H mice is associated with increased expression of the molecule OX2 seen on host dendritic cells, along with a marked polarization in cytokine production from lymphocytes harvested from the transplanted animals, with preferential production of IL-4, IL-10, and TGF-ß on donor-specific restimulation in vitro, and decreased production of IL-2, IFN-{gamma}, and TNF-{alpha} compared with non-portal vein-immunized control transplanted mice. The increased renal allograft survival and the altered cytokine production are abolished by infusion of anti-mouse OX2 mAb (3B6). Infusion of a soluble OX2:Fc immunoadhesin can itself produce significant prolongation of xeno- and allografts in mice. We have used FITC-conjugated OX2:Fc to characterize cells expressing a ligand (OX2L) for OX2, and provide evidence that subpopulations of LPS-stimulated splenic macrophages, Con A-activated splenic T cells, and the majority (>80%) of {gamma}{delta}TCR+ T cells express this ligand. We show below that F4/80+, OX2L+ splenic macrophages, admixed with OX2:Fc, represent a potent immunosuppressive population capable of causing more profound inhibition of alloreactivity in vitro or in vivo than that seen using either OX2:Fc or OX2+ (or OX2L+) cells alone. Immunoregulation by this OX2L+ population occurs in an MHC-restricted fashion.




This article has been cited by other articles:


Home page
J. Immunol.Home page
R. M. Gorczynski, Z. Chen, W. He, I. Khatri, Y. Sun, K. Yu, and I. Boudakov
Expression of a CD200 Transgene Is Necessary for Induction but Not Maintenance of Tolerance to Cardiac and Skin Allografts
J. Immunol., August 1, 2009; 183(3): 1560 - 1568.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
S. A. R. Rezaee, C. Cunningham, A. J. Davison, and D. J. Blackbourn
Kaposi's sarcoma-associated herpesvirus immune modulation: an overview
J. Gen. Virol., July 1, 2006; 87(7): 1781 - 1804.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. C. Jenmalm, H. Cherwinski, E. P. Bowman, J. H. Phillips, and J. D. Sedgwick
Regulation of Myeloid Cell Function through the CD200 Receptor
J. Immunol., January 1, 2006; 176(1): 191 - 199.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
D.-X. Chen, H. He, and R. M. Gorczynski
Synthetic peptides from the N-terminal regions of CD200 and CD200R1 modulate immunosuppressive and anti-inflammatory effects of CD200-CD200R1 interaction
Int. Immunol., March 1, 2005; 17(3): 289 - 296.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Taylor, K. McConnachie, C. Calder, R. Dawson, A. Dick, J. D. Sedgwick, and J. Liversidge
Enhanced Tolerance to Autoimmune Uveitis in CD200-Deficient Mice Correlates with a Pronounced Th2 Switch in Response to Antigen Challenge
J. Immunol., January 1, 2005; 174(1): 143 - 154.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Gorczynski, Z. Chen, Y. Kai, L. Lee, S. Wong, and P. A. Marsden
CD200 Is a Ligand for All Members of the CD200R Family of Immunoregulatory Molecules
J. Immunol., June 15, 2004; 172(12): 7744 - 7749.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
D. Messmer, B. Messmer, and N. Chiorazzi
The global transcriptional maturation program and stimuli-specific gene expression profiles of human myeloid dendritic cells
Int. Immunol., April 1, 2003; 15(4): 491 - 503.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Voisine, F.-X. Hubert, B. Trinite, M. Heslan, and R. Josien
Two Phenotypically Distinct Subsets of Spleen Dendritic Cells in Rats Exhibit Different Cytokine Production and T Cell Stimulatory Activity
J. Immunol., September 1, 2002; 169(5): 2284 - 2291.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
D. A. Clark, J.-W. Ding, G. Yu, G. A. Levy, and R. M. Gorczynski
Fgl2 prothrombinase expression in mouse trophoblast and decidua triggers abortion but may be countered by OX-2
Mol. Hum. Reprod., February 1, 2001; 7(2): 185 - 194.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.